Detalhe da pesquisa
1.
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Hepatology
; 79(5): 1220-1238, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934656
2.
The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study.
Hepatology
; 77(6): 2041-2051, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651170
3.
Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.
J Vasc Interv Radiol
; 34(8): 1364-1371, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100199
4.
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Hepatology
; 74(6): 2952-2964, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255381
5.
Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
Am J Gastroenterol
; 116(10): 2079-2088, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158464
6.
Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study.
Liver Transpl
; 27(3): 329-340, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217178
7.
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
J Hepatol
; 73(3): 540-548, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243960
8.
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Gastroenterology
; 157(6): 1506-1517.e1, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401140
9.
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.
Clin Gastroenterol Hepatol
; 17(4): 774-783.e4, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29913280
10.
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.
Hepatology
; 66(4): 1083-1089, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498551
11.
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
Gut
; 66(10): 1844-1852, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418632
12.
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.
Gastroenterology
; 150(2): 419-29, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497081
13.
Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.
Liver Transpl
; 22(1): 24-33, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519873
14.
Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
Hepatology
; 61(6): 1793-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25846014
15.
CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
Liver Int
; 33(1): 72-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23107586
16.
Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.
Hepatol Res
; 43(7): 757-64, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23193965
17.
Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.
Dig Dis Sci
; 58(5): 1403-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23306846
18.
Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.
Eur J Gastroenterol Hepatol
; 34(4): 435-442, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750323
19.
Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate.
Eur J Gastroenterol Hepatol
; 33(1): 102-106, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243349
20.
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
Hepatology
; 49(6): 1838-46, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291790